Oct 3, 20221 min readEducating Your Patients on IMBRUVICA Treatment for CLL/SLL: A Case-based Approach ~ Tomorrow night! Click to Register Full flyer info:Octoberinvite.pdfDownload PDF • 330KB
The First and Only Novel Targeted Therapy Approved for mCRC, Regardless of Mutation Status, in More Than a Decade1-3
![Boston_H_color[33632]_edited.png](https://static.wixstatic.com/media/e60c5c_0b72738a80554196840094a8e387c5ed~mv2.png/v1/fill/w_338,h_77,al_c,q_85,usm_0.66_1.00_0.01,enc_auto/Boston_H_color%5B33632%5D_edited.png)
Comments